Sermorelin / GHRP-2 Blend
GHRH plus the best-validated secretagogue, with its appetite effect included.
For research purposes only. These products are not intended to diagnose, treat, cure, or prevent any disease. By purchasing, you confirm these products will be used for legitimate research purposes.
About Sermorelin / GHRP-2 Blend
A 10mg vial split 5mg sermorelin and 5mg GHRP-2. GHRP-2 is the most clinically established compound in the secretagogue family — Japan approved it as pralmorelin, a diagnostic agent for hypothalamic-pituitary function — so this pairs a GHRH analogue with the secretagogue that has the strongest human validation. What comes with it is appetite. A controlled study in healthy men showed GHRP-2 measurably increases food intake, and it produces a transient rise in ACTH, cortisol, and prolactin alongside GH. If the goal is a leaner body composition, that appetite effect works against you, and the fixed 1:1 ratio means you cannot dial back the GHRP-2 without also reducing the sermorelin. No study has examined the combination.
Key Benefits
- Pairs GHRH signalling with the best-validated secretagogue in the family
- Both components clear quickly, so one schedule suits both
- GHRP-2 is an approved diagnostic agent in Japan
Set a goal (top of the page) to see how Sermorelin / GHRP-2 Blend scores against it, and what the better-evidenced alternatives are.
Category Ratings
How to Take
Common Side Effects
- Increased appetite from the GHRP-2 component
- Transient cortisol and prolactin elevation
- Water retention
- Tingling or numbness in hands
- Flushing
- Fixed ratio prevents adjusting the GHRP-2 dose alone
Legal & Regulatory Status
Research use only; not FDA-approved. GHRP-2 is approved in Japan as a diagnostic agent only. No study exists on the combination. Both components are WADA-prohibited.
Safety and regulatory details for FDA-approved compounds are drawn from the official product label via openFDA; clinical development status reflects ClinicalTrials.gov. This information is provided for research reference, is not endorsed by the FDA, and may not be complete or current.
Research & Sources
- Pralmorelin (GHRP-2) drug profile and development status (PMID 15230633)
- GHRP-2, like ghrelin, increases food intake in healthy men (PMC2824650)
- Review: diagnosis of growth hormone deficiency (covers sermorelin/Geref) (PMC6941588)
Sources are selected for reliability (peer-reviewed literature, openFDA, ClinicalTrials.gov) but this is a research summary, not medical advice, and may not be exhaustive.
Prices at quality-checked sources · as of August 2026 (8 days ago)
- 5mg + 5mg (10mg total) $101.56
Observed on each vendor’s public listing — see how these sources are vetted. Peptide Concierge doesn’t sell peptides and isn’t affiliated with any vendor; confirm current pricing at the source.
Builds a working set shared across the stack builder, calculator, scheduler and compare.